Multiplexed protein array platforms for analysis of autoimmune diseases.

Published

Journal Article (Review)

Several proteomics platforms have emerged in the past decade that show great promise for filling in the many gaps that remain from earlier studies of the genome and from the sequencing of the human genome itself. This review describes applications of proteomics technologies to the study of autoimmune diseases. We focus largely on biased technology platforms that are capable of analyzing a large panel of known analytes, as opposed to techniques such as two-dimensional gel electrophoresis (2DIGE) or mass spectroscopy that represent unbiased approaches (as reviewed in 1). At present, the main analytes that can be systematically studied in autoimmunity include autoantibodies, cytokines and chemokines, components of signaling pathways, and cell-surface receptors. We review the most commonly used platforms for such studies, citing important discoveries and limitations that exist. We conclude by reviewing advances in biomedical informatics that will eventually allow the human proteome to be deciphered.

Full Text

Duke Authors

Cited Authors

  • Balboni, I; Chan, SM; Kattah, M; Tenenbaum, JD; Butte, AJ; Utz, PJ

Published Date

  • 2006

Published In

Volume / Issue

  • 24 /

Start / End Page

  • 391 - 418

PubMed ID

  • 16551254

Pubmed Central ID

  • 16551254

International Standard Serial Number (ISSN)

  • 0732-0582

Digital Object Identifier (DOI)

  • 10.1146/annurev.immunol.24.021605.090709

Language

  • eng

Conference Location

  • United States